Drug intelligence / Profile preview

Parodontax (GSK)

Development stage
Unknown
Lead developer
HALEON
Modality
Small Molecules
Administration
Topical
01

Overview

Parodontax is a specialized topical toothpaste formulation containing a high concentration of sodium bicarbonate (67% w/w) and sodium fluoride (0.221-0.31% w/w), developed by GSK Consumer Healthcare for the treatment and prevention of gingivitis. The product works through a dual mechanism: the high concentration of sodium bicarbonate enhances the physical disruption and removal of dental plaque biofilm during brushing, which directly reduces gingival inflammation and bleeding. Simultaneously, sodium fluoride provides anti-caries benefits by promoting the remineralization of tooth enamel and increasing its resistance to acid-producing oral bacteria. Multiple randomized controlled trials have demonstrated that twice-daily use of this high-bicarbonate formulation significantly improves clinical markers of gingival health, such as the Modified Gingival Index (MGI) and Bleeding Index (BI), compared to standard fluoride toothpastes in adults with mild-to-moderate gingivitis.

Brand names
ParodontaxCorsodyl Original Toothpaste
Other names
sodium bicarbonate and sodium fluoride toothpastesodium bicarbonate experimental dentifrice
02

Targets

Oral plaque bacteria

Beyond the preview

Go deeper on Parodontax (GSK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parodontax (GSK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call